BSPM Stock Chart & Stats
$0.05
$0.00(0.00%)
At close: 4:00 PM EDT
$0.05
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.05 - $0.05
Previous CloseN/A
Volume100.00
Average Volume (3M)12.00
Market Cap
$264.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-240.98
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,637,000
10 Day Avg. Volume0
30 Day Avg. Volume12
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BSPM FAQ
What was Biostar Pharmaceuticals’s price range in the past 12 months?
Biostar Pharmaceuticals lowest stock price was $0.05 and its highest was $0.05 in the past 12 months.
What is Biostar Pharmaceuticals’s market cap?
Biostar Pharmaceuticals’s market cap is $264.00.
When is Biostar Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biostar Pharmaceuticals’s earnings last quarter?
Biostar Pharmaceuticals released its earnings results on Apr 13, 2017. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.38.
Is Biostar Pharmaceuticals overvalued?
According to Wall Street analysts Biostar Pharmaceuticals’s price is currently Overvalued.
Does Biostar Pharmaceuticals pay dividends?
Biostar Pharmaceuticals does not currently pay dividends.
What is Biostar Pharmaceuticals’s EPS estimate?
Biostar Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biostar Pharmaceuticals have?
Biostar Pharmaceuticals has 2,637,000 shares outstanding.
What happened to Biostar Pharmaceuticals’s price movement after its last earnings report?
Biostar Pharmaceuticals reported an EPS of -$0.38 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Biostar Pharmaceuticals?
Currently, no hedge funds are holding shares in BSPM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biostar Pharmaceuticals
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Technical Analysis
Sonoma Pharmaceuticals
―
Sunshine Biopharma
―
PainReform
―
Universe Pharmaceuticals
―
Shuttle Pharmaceuticals Holdings, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.34% Other Institutional Investors
99.66% Public Companies and
Individual Investors